This old version of Proteopedia is provided for student assignments while the new version is undergoing repairs. Content and edits done in this old version of Proteopedia after March 1, 2026 will eventually be lost when it is retired in about June of 2026.

Apply for new accounts at the new Proteopedia. Your logins will work in both the old and new versions.


4cnm

From Proteopedia

(Difference between revisions)
Jump to: navigation, search
Current revision (12:13, 20 December 2023) (edit) (undo)
 
(4 intermediate revisions not shown.)
Line 1: Line 1:
-
{{STRUCTURE_4cnm| PDB=4cnm | SCENE= }}
 
-
===Crystal structure of human 5T4 (Wnt-activated inhibitory factor 1, Trophoblast glycoprotein)===
 
-
{{ABSTRACT_PUBMED_24582434}}
 
-
==About this Structure==
+
==Crystal structure of human 5T4 (Wnt-activated inhibitory factor 1, Trophoblast glycoprotein)==
-
[[4cnm]] is a 1 chain structure with sequence from [http://en.wikipedia.org/wiki/Human Human]. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=4CNM OCA].
+
<StructureSection load='4cnm' size='340' side='right'caption='[[4cnm]], [[Resolution|resolution]] 1.75&Aring;' scene=''>
 +
== Structural highlights ==
 +
<table><tr><td colspan='2'>[[4cnm]] is a 1 chain structure with sequence from [https://en.wikipedia.org/wiki/Homo_sapiens Homo sapiens]. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=4CNM OCA]. For a <b>guided tour on the structure components</b> use [https://proteopedia.org/fgij/fg.htm?mol=4CNM FirstGlance]. <br>
 +
</td></tr><tr id='method'><td class="sblockLbl"><b>[[Empirical_models|Method:]]</b></td><td class="sblockDat" id="methodDat">X-ray diffraction, [[Resolution|Resolution]] 1.75&#8491;</td></tr>
 +
<tr id='ligand'><td class="sblockLbl"><b>[[Ligand|Ligands:]]</b></td><td class="sblockDat" id="ligandDat"><scene name='pdbligand=CIT:CITRIC+ACID'>CIT</scene>, <scene name='pdbligand=NAG:N-ACETYL-D-GLUCOSAMINE'>NAG</scene>, <scene name='pdbligand=PEG:DI(HYDROXYETHYL)ETHER'>PEG</scene></td></tr>
 +
<tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[https://proteopedia.org/fgij/fg.htm?mol=4cnm FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=4cnm OCA], [https://pdbe.org/4cnm PDBe], [https://www.rcsb.org/pdb/explore.do?structureId=4cnm RCSB], [https://www.ebi.ac.uk/pdbsum/4cnm PDBsum], [https://prosat.h-its.org/prosat/prosatexe?pdbcode=4cnm ProSAT]</span></td></tr>
 +
</table>
 +
== Function ==
 +
[https://www.uniprot.org/uniprot/TPBG_HUMAN TPBG_HUMAN]
 +
<div style="background-color:#fffaf0;">
 +
== Publication Abstract from PubMed ==
 +
The tumor antigen 5T4/WAIF1 (Wnt-activated inhibitory factor 1; also known as Trophoblast glycoprotein TPBG) is a cell surface protein targeted in multiple cancer immunotherapy clinical trials. Recently, it has been shown that 5T4/WAIF1 inhibits Wnt/beta-catenin signaling, a signaling system central to many developmental and pathological processes. Wnt/beta-catenin signaling is controlled by multiple inhibitors and activators. Here, we report crystal structures for the extracellular domain of 5T4/WAIF1 at 1.8 A resolution. They reveal a highly glycosylated, rigid core, comprising eight leucine-rich repeats (LRRs), which serves as a platform to present evolutionarily conserved surface residues in the N-terminal LRR1. Structural and cell-based analyses, coupled with previously reported in vivo data, suggest that Tyr325 plus the LRR1 surface centered on a second exposed aromatic residue, Phe97, are essential for inhibition of Wnt/beta-catenin signaling. These results provide a structural basis for the development of 5T4/WAIF1-targeted therapies that preserve or block 5T4/WAIF1-mediated inhibition of Wnt/beta-catenin signaling.
-
==Reference==
+
Structural Insights into the Inhibition of Wnt Signaling by Cancer Antigen 5T4/Wnt-Activated Inhibitory Factor 1.,Zhao Y, Malinauskas T, Harlos K, Jones EY Structure. 2014 Feb 25. pii: S0969-2126(14)00037-9. doi:, 10.1016/j.str.2014.01.009. PMID:24582434<ref>PMID:24582434</ref>
-
<ref group="xtra">PMID:024582434</ref><references group="xtra"/><references/>
+
 
-
[[Category: Human]]
+
From MEDLINE&reg;/PubMed&reg;, a database of the U.S. National Library of Medicine.<br>
-
[[Category: Harlos, K.]]
+
</div>
-
[[Category: Jones, E Y.]]
+
<div class="pdbe-citations 4cnm" style="background-color:#fffaf0;"></div>
-
[[Category: Malinauskas, T.]]
+
== References ==
-
[[Category: Zhao, Y.]]
+
<references/>
-
[[Category: Cancer]]
+
__TOC__
-
[[Category: Cell adhesion]]
+
</StructureSection>
-
[[Category: Leucine-rich repeat]]
+
[[Category: Homo sapiens]]
-
[[Category: Mva-5t4]]
+
[[Category: Large Structures]]
-
[[Category: Signaling]]
+
[[Category: Harlos K]]
-
[[Category: Tpbg]]
+
[[Category: Jones EY]]
-
[[Category: Trovax]]
+
[[Category: Malinauskas T]]
-
[[Category: Waif1]]
+
[[Category: Zhao Y]]
-
[[Category: Wnt/beta-catenin signaling pathway]]
+

Current revision

Crystal structure of human 5T4 (Wnt-activated inhibitory factor 1, Trophoblast glycoprotein)

PDB ID 4cnm

Drag the structure with the mouse to rotate

Proteopedia Page Contributors and Editors (what is this?)

OCA

Retrieved from "http://52.214.119.220/wiki/index.php/4cnm"
Personal tools